MARC details
000 -LEADER |
fixed length control field |
05626cam a2200469 i 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221101222915.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
140430s2013 be b 000 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2014388027 |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
BIB MATCHES WORLDCAT |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
928900021X |
Qualifying information |
paperback |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9789289000215 |
Qualifying information |
paperback |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(ATU)b14205671 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)861207318 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
Modifying agency |
BTCTA |
-- |
OCLCO |
-- |
OCLCF |
-- |
YDXCP |
-- |
ATU |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
043 ## - GEOGRAPHIC AREA CODE |
Geographic area code |
e------ |
-- |
ae----- |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RA644.8.E85 |
Item number |
C55 2013 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
362.1094 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Clinical guidelines for chronic conditions in the European Union / |
Statement of responsibility, etc. |
edited by Helena Legido-Quigley, Dimitra Panteli, Josip Car, Martin McKee, Reinhard Busse. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
[Brussels?] : |
Name of producer, publisher, distributor, manufacturer |
European Observatory on Health Systems and Policies, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2013] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
©2013 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxxi, 232 pages ; |
Dimensions |
24 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
490 1# - SERIES STATEMENT |
Series statement |
Observatory studies series ; |
Volume/sequential designation |
30 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Part 1. Overview, conceptual framework and methods : -- Part 2. Mapping clinical guidelines in Europe : -- Part 3. Case studies on clinical guidelines for the prevention : -- Part 4. Are guidelines in Europe well developed? Are they well : -- Part 5. Conclusions, policy recommendations and areas for : -- Part 6. European country profiles on clinical guidelines : -- -- |
505 00 - FORMATTED CONTENTS NOTE |
Miscellaneous information |
Part 1. |
Title |
Overview, conceptual framework and methods : -- |
-- |
Clinical guidelines: background and overview -- |
-- |
Evidence-based medicine and clinical guidelines -- |
-- |
Aims and definitions of clinical guidelines -- |
-- |
The need to evaluate clinical guidelines -- |
-- |
AGREE -- |
-- |
Conceptual framework and methodology for the following sections -- |
-- |
Conceptual framework -- |
-- |
Methodology -- -- |
Miscellaneous information |
Part 2. |
Title |
Mapping clinical guidelines in Europe : -- |
-- |
Background -- |
-- |
Countries with "well-established" activities -- |
-- |
Countries "making progress" in the development of clinical guidelines -- |
-- |
Countries "recently adopting" some guidelines or where these are "in -- |
-- |
the planning stage" -- |
-- |
Regulatory basis -- |
-- |
Quality control -- |
-- |
AGREE instrument widely used -- |
-- |
No quality requirement, AGREE instrument often used -- |
-- |
Countries following an adapted version of AGREE -- |
-- |
Countries using other instruments -- |
-- |
No formal processes to assess the quality of clinical guidelines -- |
-- |
Development -- |
-- |
Institutions and organizations responsible for developing clinical guidelines -- |
-- |
Guidelines produced by a central agency -- |
-- |
Multiple actors are involved and there is a central component in place -- |
-- |
Multiple actors produce guidance without central coordination -- |
-- |
Levels of operation -- |
-- |
Local guidelines are developed by centralized guidelines -- |
-- |
Centralized guidelines are developed by regional agencies -- |
-- |
Implementation -- |
-- |
Mandatory and legal aspects -- |
-- |
Implementation aids -- |
-- |
Financial incentives -- |
-- |
Evaluation -- |
-- |
Formal evaluation of clinical guidelines -- |
-- |
No formal evaluations of clinical guidelines -- |
-- |
Discussion -- -- |
Miscellaneous information |
Part 3. |
Title |
Case studies on clinical guidelines for the prevention : -- |
-- |
and treatment of type 2 diabetes mellitus -- |
-- |
Introduction -- |
-- |
United Kingdom (England) -- |
-- |
Germany -- |
-- |
France -- |
-- |
Malta -- |
-- |
Spain -- |
-- |
Slovenia -- |
-- |
Conclusions -- -- |
Miscellaneous information |
Part 4. |
Title |
Are guidelines in Europe well developed? Are they well : -- |
-- |
implemented? Do they have any impact? A systematic review -- |
-- |
of the literature -- |
-- |
Introduction -- |
-- |
Objectives -- |
-- |
Methods -- |
-- |
Search and screening -- |
-- |
Data extraction and analysis -- |
-- |
Results -- |
-- |
Result of the literature search -- |
-- |
Methodological quality of clinical guidelines -- |
-- |
Effects of implementation strategies -- |
-- |
Effectiveness of implementation strategies -- |
-- |
Impact of clinical guidelines on process of care and patients' health outcomes -- |
-- |
Discussion -- |
-- |
Priorities for research -- |
-- |
Conclusions -- -- |
Miscellaneous information |
Part 5. |
Title |
Conclusions, policy recommendations and areas for : -- |
-- |
further study -- -- |
Miscellaneous information |
Part 6. |
Title |
European country profiles on clinical guidelines : -- |
-- |
Questionnaire template sent out to authors -- |
-- |
Austria -- |
-- |
Belgium -- |
-- |
Bulgaria -- |
-- |
Cyprus -- |
-- |
Czech Republic -- |
-- |
Denmark -- |
-- |
Estonia -- |
-- |
Finland -- |
-- |
France -- |
-- |
Germany -- |
-- |
Greece -- |
-- |
Hungary -- |
-- |
Ireland -- |
-- |
Italy -- |
-- |
Latvia -- |
-- |
Lithuania -- |
-- |
Luxembourg -- |
-- |
Malta -- |
-- |
The Netherlands -- |
-- |
Norway -- |
-- |
Poland -- |
-- |
Portugal -- |
-- |
Romania -- |
-- |
Slovakia -- |
-- |
Slovenia -- |
-- |
Spain -- |
-- |
Sweden -- |
-- |
Switzerland -- |
-- |
United Kingdom (England). |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"A new study by a team of European researchers examines for the first time the various national practices relating to clinical guidelines. It looks at the situation in 29 European countries (the EU27, plus Norway and Switzerland) and concludes that while some countries might have made progress many others are still relying on sporadic and unclear processes. There are, however, tried and tested examples which, if shared, could assure and improve the quality of health care across Europe."--Publisher's website. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chronic diseases |
Geographic subdivision |
Europe |
General subdivision |
Prevention |
9 (RLIN) |
753104 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Legido-Quigley, Helena, |
Relator term |
editor. |
9 (RLIN) |
306392 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Pantelli, Dimitra, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Car, Josip, |
Relator term |
editor. |
9 (RLIN) |
829327 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
McKee, Martin, |
Relator term |
editor. |
9 (RLIN) |
1035226 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Busse, Reinhard, |
Relator term |
editor. |
9 (RLIN) |
1091260 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Observatory studies series ; |
Volume/sequential designation |
30. |
9 (RLIN) |
1096358 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b14205671 |
b |
27-04-21 |
c |
28-10-15 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
a |
362.1094 CLI |
g |
1 |
i |
A556049B |
j |
0 |
l |
nmain |
o |
- |
p |
$100.33 |
q |
- |
r |
- |
s |
- |
t |
0 |
u |
1 |
v |
0 |
w |
1 |
x |
0 |
y |
.i13447233 |
z |
29-10-15 |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
-- |
b |
-- |
n |
Operator's initials, OID (RLIN) |
07-04-16 |
Cataloger's initials, CIN (RLIN) |
m |
First date, FD (RLIN) |
a |
-- |
eng |
-- |
be |
-- |
0 |